We examined the antitumor activity of CT in ovarian cancer cells and compared it with c-Myc inhibitor 10058-F4 by analyzing apoptosis as indicated by the levels of cleaved poly (ADP-ribose) polymerase (PARP) and caspase3 detected by immunoblotting. The gene discussed is MYC; the disease is ovarian cancer.